Trade LKFT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Lakefront Biotherapeutics American Depositary Shares (LKFT) is trading at US$29.90, down 0.10% today as of Oct 16, 16:00 EDT. The company has a market capitalisation of US$1.89B. Over the past 52 weeks, LKFT has traded between US$25.68 and US$36.24. On Syfe you can trade LKFT with $0 commission and add it to your watchlist.
| Previous close | US$29.93 |
|---|---|
| Market cap | US$1.89B |
| 52-week range | US$25.68 – US$36.24 |
| Volume | 250.89K |
| Exchange | US |
Lakefront Biotherapeutics American Depositary Shares
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
Year: 2008
Lakefront Gets FDA Orphan Drug Label for Gamgertamig
Aug 24, 8:53 PM · MT Newswires
Stay on top of LKFT
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
